Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03179410
Title PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer (PICK-NEPC)
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Andrew J. Armstrong, MD
Indications

prostate cancer

Therapies

Avelumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.